Ocular Therapeutix (OCUL) EPS (Basic) (2013 - 2026)
Ocular Therapeutix's (OCUL) quarterly EPS (Basic) came in at -$0.4 in Q1 2026, down 7.94% year-on-year from -$0.44 in Q1 2025, and down 11.54% quarter-over-quarter from -$0.36 in Q4 2025.
Ocular Therapeutix (OCUL) EPS (Basic) (2013 - 2026) Analysis & Trends
Ocular Therapeutix's EPS (Basic) history runs 14 years deep, the most recent figure standing at -$0.4 for Q1 2026.
- On a quarterly basis, EPS (Basic) fell 7.94% year-over-year to -$0.4 in Q1 2026; TTM through Mar 2026 was -$1.31, a 12.65% decrease from a year earlier, with the FY2025 full-year figure at -$2.91, down 22.07% from the prior year.
- EPS (Basic) fell to -$0.4 in Q1 2026 per OCUL's latest filing, from -$0.36 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.21 in Q4 2022 and bottomed at -$0.4 in Q1 2026.
- The 5-year median for EPS (Basic) is -$0.31 (2023), against an average of -$0.31.
- Across the five-year window, EPS (Basic) increased 17.81% in 2022 and slumped 59.78% in 2023, its largest moves.
- Year by year, EPS (Basic) stood at -$0.21 in 2022, then slumped by 59.78% to -$0.34 in 2023, then climbed by 8.66% to -$0.31 in 2024, then slipped by 16.35% to -$0.36 in 2025, then declined by 11.54% to -$0.4 in 2026.
- Per Business Quant, the three latest OCUL EPS (Basic) figures stand at -$0.4 (Q1 2026), -$0.36 (Q4 2025), and -$0.37 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Ocular Therapeutix | 1.91 Bn | 1.91 Bn | 9.46 Mn | -0.40 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.40 |
| Dec 31, 2025 | -0.36 |
| Sep 30, 2025 | -0.37 |
| Jun 30, 2025 | -0.39 |
| Mar 31, 2025 | -0.37 |
| Dec 31, 2024 | -0.31 |
| Sep 30, 2024 | -0.26 |
| Jun 30, 2024 | -0.25 |
| Mar 31, 2024 | -0.31 |
| Dec 31, 2023 | -0.34 |
| Sep 30, 2023 | -0.27 |
| Jun 30, 2023 | -0.28 |
| Mar 31, 2023 | -0.31 |
| Dec 31, 2022 | -0.21 |
| Sep 30, 2022 | -0.30 |
| Jun 30, 2022 | -0.28 |
| Mar 31, 2022 | -0.25 |
| Dec 31, 2021 | -0.26 |
| Sep 30, 2021 | -0.28 |
| Jun 30, 2021 | -0.29 |